Mavacamten significantly reduces heart obstruction in adolescents with hypertrophic cardiomyopathy, with patients experiencing a 48.5 mm Hg drop in blockage compared to minimal change in placebo groups. The drug also lowered blood markers indicating heart damage and showed promise in slowing disease progression. Separate real-world data confirms mavacamten's effectiveness as monotherapy across diverse patient populations.
Rocket Pharmaceuticals will participate in two investor conferences in March 2026, with the CEO taking part in a fireside chat and management hosting investor meetings at both events.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07527494 |
Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction |
NOT_YET_RECRUITING | NA |
| NCT07476456 |
Skeletal Muscle Multi-omics Analysis and Risk Tailoring in Sudden Cardiac Death |
NOT_YET_RECRUITING | |
| NCT07444931 |
Validation of Sudden Cardiac Arrest Risk Factors in Patients With CAD |
RECRUITING | |
| NCT07415642 |
Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD) |
NOT_YET_RECRUITING | NA |
| NCT07372196 |
Left Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After Myectomy |
RECRUITING | NA |
| NCT06964464 |
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator |
RECRUITING | PHASE4 |
| NCT06954103 |
Mechanisms And Prognosis of Stroke-Heart Syndrome |
RECRUITING | |
| NCT06857838 |
Myocardialbridge Bypass Graft Surgery Efficacy Verification |
RECRUITING | NA |
| NCT06856993 |
Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death |
RECRUITING | |
| NCT06813443 |
Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation |
RECRUITING |
